Aspiriant Holdings S3’s Johnson & Johnson JNJ Stock Holding History

Aspiriant Holdings S3’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$5.82M	Sell	56,662 -603	-1%	-$60.6K	2.5%	5
2015 Q3	$5.35M	Buy	57,265 +192	+0.3%	+$18.6K	2.46%	6
2015 Q2	$5.56M	Sell	57,073 -802	-1%	-$80.3K	2.22%	10
2015 Q1	$5.82M	Buy	57,875 +462	+0.8%	+$47K	2.32%	9
2014 Q4	$6M	Buy	57,413 +731	+1%	+$77K	2.48%	7
2014 Q3	$6.04M	Buy	56,682 +4	+0%	+$415	2.42%	5
2014 Q2	$5.93M	Sell	56,678 -958	-2%	-$96.8K	2.36%	5
2014 Q1	$5.66M	Sell	57,636 -3,093	-5%	-$287K	2.38%	4
2013 Q4	$5.56M	Sell	60,729 -232	-0.4%	-$21.4K	2.19%	8
2013 Q3	$5.29M	Buy	60,961 +37,614	+161%	+$3.37M	2.23%	9
2013 Q2	$2M	Buy	+23,347	New	+$1.98M	0.9%	46

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aspiriant Holdings S3's JNJ Position: Q4 2015 in Review

Aspiriant Holdings S3 reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q4 2015, selling an estimated $60.6K and leaving 56,662 shares worth $5.82M. The position accounts for 2.5% of the portfolio, ranked #5.

Aspiriant Holdings S3 first reported a position in JNJ in Q2 2013 and has held it in 11 quarters since. The position peaked at $6.04M in Q3 2014. 2,192 funds tracked by Wall St. Rank hold JNJ as of Q4 2015.

Aspiriant Holdings S3 held 56,662 shares of Johnson & Johnson worth $5.82M as of Q4 2015.
Aspiriant Holdings S3 sold 603 Johnson & Johnson shares in Q4 2015, an estimated $60.6K.
Johnson & Johnson made up 2.5% of Aspiriant Holdings S3's portfolio in Q4 2015, its #5 holding.
Aspiriant Holdings S3 first reported a position in Johnson & Johnson in Q2 2013 and has held it in 11 quarters since.
Aspiriant Holdings S3's Johnson & Johnson position peaked at $6.04M in Q3 2014.
2,192 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.